Arie Belldegrun Allogene Therapeutics, Inc

As of May 25, 2021


Arie Belldegrun Net Worth

  • Net worth is estimated to be at least $107.31M
  • Owns at least 5,508,169 units of Allogene Therapeutics, Inc stock

Arie Belldegrun Trading

  • Largest purchase of shares was 146,382 units , worth over $6.88M on June 4, 2020
  • In total has made about 8 transactions over 3 years
  • Usually trades in March, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Arie Belldegrun Mailing Address

  • Mailing address is Ucla School of Medicine 10833 le Conte 66-118 Chs Box 951738 Los Angeles CA 9095-1738 CA

Allogene Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Chang, M.D., Ph.D. 2020 $675,000 - - $6,550,535 $506,250 $83,256 $7,815,041
David Chang, M.D., Ph.D. 2019 $600,000 - $4,651,970 $5,327,140 $363,000 $250,000 $11,192,110
David Chang, M.D., Ph.D. 2018 $362,413 - $8,948,152 $3,070,331 $217,641 $250,000 $12,848,537
Eric Schmidt, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Eric Schmidt, Ph.D. 2019 $425,000 - $1,328,366 $1,519,700 $187,000 - $3,460,066
Eric Schmidt, Ph.D. 2018 $201,232 - - $2,299,658 $88,099 - $2,588,989
Rafael Amado, M.D. 2020 $510,000 $75,000 $561,176 $1,262,643 $255,000 - $2,663,819
Rafael Amado, M.D. 2019 $145,833 - $4,249,976 $2,759,623 $71,726 $225,000 $7,452,158
Alison Moore, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Alison Moore, Ph.D. 2019 $425,000 - $996,275 $1,519,700 $187,000 - $3,127,975
Alison Moore, Ph.D. 2018 $233,265 - - $1,401,225 $102,124 $100,000 $1,836,614
Veer Bhavnagri 2020 $425,000 - $537,490 $1,211,953 $212,500 $9,385 $2,396,328
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm

Allogene Therapeutics, Inc Insider Trading

  • The most recent transaction was 11,507 units sold on October 4, 2021 by Rafael Amado worth over $280.19K
  • In the last 3 years, insiders at Allogene Therapeutics, Inc sold an estimated value of $151.1M and bought an estimated value of $31M
  • The most active traders are David Chang, President and CEO,  Veer Bhavnagri, General Counsel,  and Alison Moore, Chief Technical Officer
  • Insider trading is most common in March, with the busiest year in 2020

Allogene Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1